This proposal outlines a strategy to build a $80-150 million revenue company that manufactures and distributes fine chemical and biologic products. The plan involves acquiring several complementary companies and integrating their operations to achieve efficiencies and expand sales and marketing globally. The life science industry is large, complex, and fragmented, creating opportunities to consolidate segments profitably. The proposal discusses targeting small companies for acquisition and leveraging the proposing team's experience in operations and industry knowledge to increase acquired companies' profitability through direct distribution and other means.